News Story #18565
Voluntary market withdrawal of at-risk frozen blood products initiated to prevent spread of WNV from affs
Read MorePosted by Clinical Lab Products | Jan 9, 2003 | Cancer, Miscellaneous |
Voluntary market withdrawal of at-risk frozen blood products initiated to prevent spread of WNV from affs
Read MorePosted by Clinical Lab Products | Jan 4, 2003 | Kidney Disease, Miscellaneous |
Tools to detect and manage kidney disease
Read MorePosted by Clinical Lab Products | Jan 2, 2003 | Cancer, Miscellaneous |
FDA approves new agents for treatment of opioid abuse
Read MorePosted by Clinical Lab Products | Nov 10, 2002 | Miscellaneous |
NHLBI launches protemics center
Read MorePosted by Clinical Lab Products | Nov 4, 2002 | Miscellaneous |
Providing high throughput clinical chemistry and immunoassay testing on one platform
Read More